Traumatic brain injury (TBI) is a global public health problem that affects the long-term cognitive, physical, and psychological health of patients, while also having a major impact on family and caregivers. In stark contrast to the effective trials that have been conducted in other neurological diseases, nearly 30 studies of interventions employed during acute hospital care for TBI have failed to identify treatments that improve outcome. Many factors may confound the ability to detect true and meaningful treatment effects. One promising area for improving the precision of intervention studies is to optimize the validity of the outcome assessment battery by using welldesigned tools and data collection strategies to reduce variability in the outcome data. The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, conducted at 18 sites across the United States, implemented a multidimensional outcome assessment battery with 22 measures aimed at characterizing TBI outcome up to 1 year postinjury. In parallel, through the TBI Endpoints Development (TED) Initiative, federal agencies and investigators have partnered to identify the most valid, reliable, and sensitive outcome assessments for TBI. Here, we present
T RAUMATIC BRAIN INJURY (TBI) is a global health problem impacting 3 million to 5 million people in the United States and contributing to lifelong physical, cognitive, and psychological consequences. 1 Although recent research efforts have increased our understanding of TBI pathophysiology 2, 3 and chronic sequelae, [4] [5] [6] [7] [8] acute clinical trials have either failed to improve long-term outcome or demonstrated small effect sizes. The relative futility of these studies may be related to the complex array of injury and noninjury factors that characterize TBI, rather than failure of specific treatment interventions. For example, animal models of TBI typically control for injury location and severity, as well as age, gender, and genotype, 9, 10 and focus on one construct of recovery, such as memory. Human TBI studies typically enroll highly heterogeneous samples with varied injury, demographic, environmental, and genetic characteristics and assess recovery across a spectrum of domains. A series of opinion and review papers have summarized the broad range of issues that may contribute to failed trials and provided recommendations that may lead to improved outcomes in future studies. [11] [12] [13] [14] These reports recognize that variability in medical management, crude methods for stratifying patients by injury severity, poor participant compliance, and other factors may contribute to the large underlying between-participant variability that cannot be overcome even with the most effective treatment.
One challenge faced by investigators conducting TBI studies is how to control for sources of error that emanate from the participant, examiner, or outcome measure that may mask actual differences between study groups. Standardization of study procedures (in particular, outcome assessment) to minimize potential sources of variance is especially important in multisite longitudinal studies focused on documenting the natural course of recovery after TBI, predicting functional outcome, and detecting treatment effects.
The purpose of the current review is 2-fold: (1) to identify potential areas of inconsistency and heterogeneity in conducting multisite longitudinal TBI outcome assessment and (2) to describe strategies intended to optimize outcome assessment. Toward this aim, we discuss lessons learned during the protocol design and implementation phases of the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI, https://tracktbi.ucsf.edu, ClinicalTrials.gov identifier: NCT02119182) study and the TBI Endpoints Development (TED, https://tbiendpoints.ucsf.edu) 15 Initiative. TRACK-TBI is an 18-site collaboration that aims to create a comprehensive data set integrating clinical, imaging, proteomic, and genomic biomarkers, with a multidimensional outcome assessment battery designed for patients with mild to severe TBI across the first year postinjury. The TED initiative is a multidisciplinary effort funded by the US Department of Defense, working to develop and harmonize a TBI metadata set comprising data elements drawn largely from completed TBI clinical trials.
TRACK-TBI investigators with expertise in each of the outcome domains convened to develop the Flexible Outcome Assessment Battery (FAB), which comprises 22 measures that assess global functioning, cognitive performance, symptoms, social participation, quality of life, and psychological health. The battery is tailored to participants on the basis of their current level of function, and most of the measures are included in the TBI Common Data Elements (https://www.common dataelements.ninds.nih.gov). Participants are assessed in person at 2 weeks, 6 months, and 12 months postinjury and by telephone at 3 months postinjury. Thus, the FAB enables acquisition of both cross-sectional and longitudinal data across the full spectrum of TBI severity. Through its participation in the International Initiative for TBI Research (InTBIR, https://intbir.nih.gov), a partnership between the National Institutes of Health, the European Commission, the Canadian Institutes of Health Research, One Mind Foundation, and the Department of Defense, the TRACK-TBI assessment platform was harmonized with the outcome battery currently employed by the Collaborative European NeuroTrauma Effectiveness Research study (CENTER-TBI, https://www.center-tbi.eu/). In combination, TRACK-TBI and CENTER-TBI will enroll 8000 participants, creating the largest harmonized international TBI data set assembled to date. In parallel, the TED effort provides an unprecedented opportunity to conduct clinical outcome assessment (COA) validation studies, based on a large data repository, aimed at identifying measures that are best suited for use in TBI clinical trials, including US Food and Drug Administration (FDA)-sponsored TBI drug and device trials.
The TRACK-TBI outcome assessment battery adheres to FDA principles that guide selection of COAs for use in clinical trials. Key principles include specification of what the COA is measuring (ie, concept of interest) and Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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149 the context within which it is being used (ie, context of use). These principles are seeded in the work plans for both TRACK-TBI and TED.
ERROR IN OUTCOME ASSESSMENT
Outcome assessment is influenced by inherent errors that emanate from the participant, the examiner, and the outcome measure itself. 16 These factors can influence cross-sectional and longitudinal outcomes. Here, we use error to refer to uncontrolled variability in participant preinjury characteristics and nature and severity of injury that influence outcome after TBI as well as variation in assessment administration, scoring procedures and psychometric properties. Table 1 lists examples of each source of error and describes strategies to minimize exposure to these risks.
Participant-related sources of error
Participant characteristics such as age, gender, level of education, and socioeconomic status may impact outcome independent of injury characteristics and may be highly variable across individuals. A plan should be developed in advance to monitor participant demographics and adjust enrollment strategies, if necessary, to ensure that baseline sample characteristics are balanced across treatment arms and comparable across sites. This process will enable monitoring of appropriate matching of the injured and control groups on critical demographic and other variables known to impact clinical outcome assessments. The effects of differences in these variables can be minimized by adopting analytic strategies, such as using normalized scores that account for age, sex, and education, and applying regression methods. The TRACK-TBI initiative employed comprehensive enrollment and follow-up interviews to probe premorbid characteristics and capture changes (such as non-study-related postinjury illness and injury) that occur during the course of the study. Specific statistical analyses were planned to account for potential differences in these participant characteristics.
Other factors that may affect cognitive test performance and responses to self-report questions that are not related to the TBI include altered cognitive status due to premorbid medical and psychological conditions, intoxication, test-taking attitude, impaired awareness, poor effort, and exposure to sedating medications. Illness, pain, or fatigue may prompt refusal, hurried completion of measures, or unreliable responses. Language barriers can be a problem for participants who are multilingual or must rely on an interpreter. Sensory and physical impairments can compromise responses on performance-based measures, especially those that are timed. Deficits in executive function, whether related or unrelated to the TBI, may affect comprehension, judgment, and recall. 17 Finally, participants may intentionally perform poorly to secure compensation or retain services.
Many of the factors listed earlier are difficult to ascertain until the assessment is underway. When detected, examiners should record their observations and determine whether the problem can be mitigated using strategies that preserve the standardized test procedures. 17 The TRACK-TBI FAB was specifically designed to include measures that could be completed in a valid manner by participants at all levels of function (or, in some instances, surrogates), ranging from those who have not regained consciousness (evaluated with the Coma Recovery Scale-Revised 18 ) to those capable of completing self-report measures and standardized neuropsychological tests. Test Completion Codes, modified from a prior TBI clinical trial, 19 were used to standardize validity ratings for each measure administered (see Table 2 ). Performance was coded as valid (if the measure was completed in full with no threats to validity), attempted but not completed (if the measure was not completed or judged invalid), or not attempted (if no attempt was made to administer the measure). Each code described why performance was judged invalid (eg, severe neurological/cognitive impairment, poor effort, suspected language barrier), and examiners were instructed to make additional notation as to why the assessment was deemed invalid. Apart from ensuring consistent test administration procedures, completion codes provide an additional source of information regarding the factors that affect outcome measure administration in participants diagnosed with TBI.
In longitudinal studies of outcome in TBI, it is critical to ensure that participants followed are representative of those who were originally enrolled in the study. When participants do not return for follow-up, bias may be introduced, as there may be systematic differences between those followed and not followed. For example, participants who are lost to follow-up may be more likely to be employed and therefore higher functioning. Alternatively, those who miss follow-up appointments may be from a lower socioeconomic bracket and less able to obtain transportation. To mitigate these challenges, study sites should make efforts to schedule follow-up assessments during nonstandard business hours, arrange and reimburse transportation, and make other accommodations to encourage participants to return for visits. Additional strategies to maximize participant follow-up have been developed by the Traumatic Brain Injury Model Systems and can be found at: https://www.tbindsc.org/SOP.aspx.
Examiner-related sources of error
The validity of an assessment rests on selection of the most appropriate measures for the target population Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
www.headtraumarehab.com 20, 21 These differences are important, as they can influence completion time, the key metric for this measure. Another example of examiner bias relates to the Glasgow Outcome Scale-Extended (GOSE), 22 the most widely used measure in TBI clinical trials. 23 In some studies, the GOSE 22 score is intended to reflect disability that is specifically attributable to the TBI. In others, the GOSE 22 score represents the cumulative effects of all central and peripheral injuries and serves as a measure of global function. These procedural differences can introduce large variations at the group level that overwhelm the effects of the study treatment, further emphasizing the importance of adherence to administration and scoring guidelines.
TRACK-TBI investigators with expertise in TBI outcome assessment vetted multiple versions of each measure in the FAB and achieved consensus on the most appropriate instructions and scoring criteria relative to the study aims. A comprehensive Standard Operating Procedure (SOP) was developed that included a decision-making algorithm designed to align the subject's level of function with appropriate clinical outcome measures. Testing instructions, timing parameters, and the order of test administration were also explicitly described. All forms were provided via a central electronic database that was regularly monitored and updated. The Clinical Data Interchange Standards Consortium, an organization that develops standards and innovations to streamline medical research, provided guidance on best practices for collecting TBI data (see Therapeutic Area Data Standards User Guide for TBI, available at: www.cdisc.org/sites/default/files/members/ standard/ta/traumatic-brain-injury/taug-tbi-v1.pdf ).
Patient-reported outcome measures frequently include questions that ask participants to anchor responses to a specific time frame. For example, the Short Form-12 (SF-12) 24 asks participants to rate their health over the past 4 weeks, the Brief Symptom Inventory-18 (BSI-18) 25 rates symptoms that have been distressing over the past 2 weeks, and the Rivermead Postconcussion Questionnaire (RPQ) 26 anchors responses to the past week or 14 days, depending on the version. Two potential sources of variance may result from these inconsistent time anchors. First, additional cognitive burden is placed on the participant when time anchors are not consistent across measures and switching between time anchors is required throughout an assessment battery. The impact of changing response epochs across measures in a single session in this population has not been studied, and examiners must be especially vigilant to direct the participant's attention to the specific time period in question.
Second, the prescribed time anchors may not be appropriate for the study design or aims. For example, in the TRACK-TBI study, the first follow-up assessment occurred at approximately 2 weeks postinjury. The RPQ 26 is available in versions that assess a 7-and 14-day time period; the latter was selected for TRACK-TBI to ensure the participant's frame of reference aligned with the 2-week follow-up assessment. However, the Posttraumatic Stress Disorder Checklist (PCL-5) 27 anchors responses to the prior month. To avoid ratings that reflect general health before and/or after the injury at the initial follow-up assessment, examiners were instructed to replace the anchor instruction with "since your injury." Altering standardized test instructions should be avoided. In circumstances in which it is necessary to modify the instructions, permission from the publisher may be required. While modification of published and validated assessments should be limited to the extent possible, it is occasionally necessary to accomplish study aims. In this case, changes should be approved by a committee of experts and implemented as early into data collection as possible to avoid variance in responses due solely to modification of instructions, test items, or scoring rules. This break from use of standardized forms has implications for making comparisons across data acquired both within and across studies, and normative data sets based on the original form should not be used.
A different type of anchor is related to the index event that led to enrollment in the study. Some measures (eg, RPQ, 26 32, 33 which utilize drawings and word lists, respectively, examiners were provided with precise instructions on how to present the stimuli to ensure that exposure remained constant across sites. TRACK-TBI employed a multistep data quality assurance process to reduce examiner error in which a core group of outcomes experts vetted each measure, provided extensive training to examiners, "certified" examiners through video-recorded test administration simulations, and conducted frequent teleconferences to address issues and questions.
A final source of extraneous variability may result from errors in data entry, transcription, and conversion. Data quality assurance procedures should be established at the local level to minimize the risk of these errors. Data quality monitoring should include procedures designed to identify transcription errors when transferring data from paper to electronic forms, miscalculation of raw scores, errors converting raw scores to standard scores, and conflicting responses on two measures assessing the same construct. Each local site within TRACK-TBI developed monitoring plans to oversee data quality and minimize data entry and transcription errors. In addition, all subject data across all sites were entered into an electronic data system (QuesGen Systems, Inc; Burlingame, California) that generated automatic error reports for select data fields. To move through the data entry fields, examiners had to address all flagged error fields and reconcile all errors. In addition to local monitoring, when feasible, centralized data audits should be conducted by an independent party to address data quality studywide.
Measure-related sources of error
Sources of error that emanate from the measure are often the result of ambiguous administration and scoring guidelines, unclear wording of questions and test items, and practice effects that result from repeated assessments. For example, responses on the RPQ 26 should reflect changes in symptom severity relative to the preinjury baseline. However, the instructions can be misinterpreted such that only current symptom severity is reported, or the response reflects the change in symptom severity compared with a prior assessment. There are also scoring nuances that are not intuitive and can lead to error (eg, depending on the scoring algorithm applied, responses of "1" may or may not be converted to "0" for analysis). Thus, extra training is required to ensure examiners understand the conceptual framework for the assessment. Multiple scoring schemas are also available for the BSI-18 25 and the Brief Test of Adult Cognition by Telephone). [34] [35] [36] Given these potential sources of error, examiners must be certain that they and the participants have adequate understanding of the items, response options, and scoring method.
In multisite studies, problems can arise when different versions of the same test are available. For example, under the auspices of InTBIR, an effort was made to harmonize the outcome assessment batteries used in the TRACK-TBI and CENTER-TBI studies. The investigators subsequently discovered that the 2 consortia were using different versions of the SF-12. 24 To reconcile this problem, a conversion system was developed to accommodate the variations in scoring between the 2 studies. In addition, when a repeated-measures design is employed, alternate forms are sometimes required to avoid practice effects across assessments. In the TRACK-TBI study, the RAVLT 32,33 is administered 3 times over 12 months. Therefore, 2 alternate forms of equal difficulty were incorporated into the protocol. 37, 38 To accommodate Spanish-speaking participants, both forms were translated into Spanish but were not tested for equivalency. A post hoc analysis will test for differences in the distribution of scores on the forms and inform a determination regarding their comparability. Thorough investigation of all forms for each measure is required to ensure the correct versions are included in the final battery of assessments. For a table of measures used in TRACK-TBI and factors that may introduce error into the assessment, see Table 3 .
Finally, during the design of the study, investigators are tasked with selecting the most appropriate measures to assess outcome. This decision should rest in large part on the psychometric robustness of the measures under consideration. A key factor in the decision-making process relates to the adequacy of the COA's internal construct validity. The investigator should know whether the COA's items or scores have been verified to reflect the phenomenon that the COA intends to measure and whether the underlying construct is unidimensional or is comprised of more than 1 explanatory factor. Interpretation of the results of the measure may be unreliable unless these and other critical psychometric features have been assessed. Modern approaches to outcome measure development such as Item Response Theory and Rasch analysis provide the means to answer these questions. Apart from these basic psychometric properties, COA stakeholders are increasingly interested in understanding the clinical significance or ecological validity of the results of a particular outcome measure. This can be accomplished by determining the COA's responsiveness-the extent to which a change in the COA over a specific period of time corresponds to a change in an alternate, independent measure of the same construct. 45, 46 The minimum clinically important difference is a useful measure of external responsiveness that anchors COA performance to some change that has been judged to be meaningful to the patient. With few exceptions (eg, the GOSE 22 ), outcome measures used in TRACK-TBI have been tested using contemporary measurement techniques and have been determined to be psychometrically sound.
IMPORTANCE OF THE HEALTHY CONTROL COHORT
Most TBI outcome and natural history studies include a control group for normative comparison against the population of interest. 47 Control participants are typically selected from the community to match the target population on important demographic characteristics such as age, gender, education, and race, although other variables (eg, socioeconomic status) are also sometimes included. Recruiting from the community is advantageous, as there is a large pool of potential participants who are relatively accessible. However, some studies have shown that recruiting control participants from the community is not sufficient, as the preinjury profile of this cohort differs from TBI participants. Thus, preinjury characteristics may be the predominant cause of differences between participants who have sustained a TBI and healthy individuals.
There is evidence that some of the variance in outcome following mild TBI may be attributable to the general effects of the trauma, rather than specific effects caused by the brain injury [48] [49] [50] [51] (although for an alternate conclusion, see Mathias et al 52 and Beauchamp et al 53 ). To address this concern, individuals who have experienced orthopedic injuries have been recruited as participants to control for nonspecific effects of traumatic injury, including posttraumatic stress and general inflammation. [54] [55] [56] This cohort also provides a control for preexisting risk factors (eg, substance use, impulsivity, participation in contact sports) that Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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increase the probability of an injury. [57] [58] [59] Nonetheless, careful screening for TBI is advisable, as occult brain injury in patients with orthopedic injury could obscure between-group differences. 59 "Birds of a feather" controls (ie, friends and relatives of the patient) permit investigators to control for additional influences on outcome. 60 In addition to sharing demographic features, this cohort controls for exposure to environmental risk factors, personality characteristics, and other influences related to acculturation. 61 Both orthopedic and friend control groups were recruited for the TRACK-TBI study to parse the effects of the TBI from nonspecific demographic or general trauma effects.
FUTURE RESEARCH DIRECTIONS
Optimization of the approach to outcome assessment in multicenter trials is necessary to maximize the probability that variability in the data can be attributed to the effects of the brain injury or of the treatment. Before initiating data collection, sources of error related to the participant, the examiner, and the measure should be considered and management strategies implemented to mitigate their impact. Poor control of participant-, examiner-, and measure-related sources of error may lead to systematic bias in data collection (eg, selection bias) 62 and interpretation (eg, attribution of outcomes to the brain injury rather than other influencing factors). 63 While each study has unique aims, and employs different outcome assessment measures, there are some overarching principles that can increase fidelity and help maintain the integrity of the data.
RECOMMENDATIONS FOR OPTIMIZING CLINICAL OUTCOME ASSESSMENT IN MULTICENTER LONGITUDINAL TBI STUDIES
On the basis of lessons learned through our experience with TRACK-TBI and TED, we have developed a 6-step plan for optimizing outcome assessment in multicenter, longitudinal TBI studies:
1. Convene an Expert Working Group (EWG) comprised of subject matter experts in clinical outcome assessment. The role of the Outcomes EWG is to triage and select COAs, oversee ongoing examiner training activities, monitor data quality, and troubleshoot over the course of the study. 2. Develop an SOP manual that details all aspects of the outcome assessment protocol. The SOP should describe the purpose of each measure, the order of administration, and the procedures for administration and scoring. A process for updating the manual and disseminating updates to participating sites should be established. The SOP manual and all assessment measures should be housed in a central, easily accessible repository. 3. Provide in-person and electronic training modules for all study examiners to promote uniformity in administration and scoring of outcome measures. Develop and implement a procedure for certifying examiner competency before authorizing data collection (eg, require videotaped demonstration of test administration). 4. Hold regularly scheduled teleconferences with outcome data collectors to address questions, adjudicate unusual test administration and scoring circumstances, apprise participants of SOP amendments, and conduct ongoing training. 5. Establish a schedule for retraining examiners and consider using multimedia training devices (eg, videotaped simulations, webinars, written manuals, case presentations). 6. Mandate that participating sites have a local plan for data quality assurance and, when possible, conduct on-site audits studywide.
CONCLUSION
Successful multisite, longitudinal TBI outcomes research relies on precise assessment of the domains of interest. Minimizing the risk of error from multiple sources (ie, subject, examiner, measure) will increase the likelihood that the outcomes reported reflect the effects of the injury or treatment intervention rather than nonspecific factors that may influence outcome. The experience-based recommendations provided here represent reasonable steps that should be considered to help ensure that high-quality outcome data are obtained across participating sites.
